JP2022506108A5 - - Google Patents

Info

Publication number
JP2022506108A5
JP2022506108A5 JP2021523276A JP2021523276A JP2022506108A5 JP 2022506108 A5 JP2022506108 A5 JP 2022506108A5 JP 2021523276 A JP2021523276 A JP 2021523276A JP 2021523276 A JP2021523276 A JP 2021523276A JP 2022506108 A5 JP2022506108 A5 JP 2022506108A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
sequence shown
antibody
Prior art date
Application number
JP2021523276A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022506108A (ja
JPWO2020083979A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/078855 external-priority patent/WO2020083979A1/en
Publication of JP2022506108A publication Critical patent/JP2022506108A/ja
Publication of JP2022506108A5 publication Critical patent/JP2022506108A5/ja
Publication of JPWO2020083979A5 publication Critical patent/JPWO2020083979A5/ja
Pending legal-status Critical Current

Links

JP2021523276A 2018-10-23 2019-10-23 グリコシル化ApoJに特異的な抗体およびその使用 Pending JP2022506108A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18382752.6 2018-10-23
EP18382752 2018-10-23
PCT/EP2019/078855 WO2020083979A1 (en) 2018-10-23 2019-10-23 Antibodies specific for glycosylated apoj and uses thereof

Publications (3)

Publication Number Publication Date
JP2022506108A JP2022506108A (ja) 2022-01-17
JP2022506108A5 true JP2022506108A5 (https=) 2022-06-14
JPWO2020083979A5 JPWO2020083979A5 (https=) 2022-06-14

Family

ID=64426823

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021523276A Pending JP2022506108A (ja) 2018-10-23 2019-10-23 グリコシル化ApoJに特異的な抗体およびその使用

Country Status (13)

Country Link
US (1) US20210388108A1 (https=)
EP (1) EP3870614A1 (https=)
JP (1) JP2022506108A (https=)
KR (1) KR20210081397A (https=)
CN (1) CN113366021A (https=)
AU (1) AU2019365391A1 (https=)
BR (1) BR112021006516A2 (https=)
CA (1) CA3115887A1 (https=)
IL (1) IL282384A (https=)
MA (1) MA53980A (https=)
MX (1) MX2021004684A (https=)
SG (1) SG11202103124WA (https=)
WO (1) WO2020083979A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof
CN120699894A (zh) * 2024-03-25 2025-09-26 中国科学院分子细胞科学卓越创新中心 Clusterin阳性心脏类器官及其应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4419446A (en) 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US4965199A (en) 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
AU632065B2 (en) 1988-09-23 1992-12-17 Novartis Vaccines And Diagnostics, Inc. Cell culture medium for enhanced cell growth, culture longevity and product expression
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
WO1993006217A1 (en) 1991-09-19 1993-04-01 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES
MD1367C2 (ro) 1992-11-13 2000-11-30 Idec Pharmaceuticals Corporation Metode de tratament al limfomului celulelor B, anticorpi anti-CD20, hibridom.
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
ITRM20040098A1 (it) * 2004-02-25 2004-05-25 Univ Roma Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi.
US10155816B2 (en) 2005-11-28 2018-12-18 Genmab A/S Recombinant monovalent antibodies and methods for production thereof
ES2364169B1 (es) * 2010-02-09 2012-07-10 CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (Titular al 50%) Uso de las isoformas de apo j como biomarcadores de lesión tisular.
CA2868391A1 (en) 2012-04-02 2013-10-10 Stephane Bancel Polynucleotides comprising n1-methyl-pseudouridine and methods for preparing the same
WO2017139975A1 (en) * 2016-02-19 2017-08-24 Huiru Wang Antibodies against n-acetylglucosamine and n-acetyl-galactosamine
EP3232200A1 (en) * 2016-04-12 2017-10-18 Institut Catalá De Ciencies Cardiovasculars (ICCC) Methods and kits for the diagnosis and risk stratification of patients with ischemia

Similar Documents

Publication Publication Date Title
CN105765385B (zh) 预测出现主要不良心脏事件的风险的方法
US20230408521A1 (en) Gdf-15 as a diagnostic marker for melanoma
CN113892031B (zh) 混合检测PCT和Presepsin的试剂盒、方法以及应用
EP3248015B1 (en) Compounds and methods for the detection of calprotectin
CN104470942A (zh) 生物标志物
US20190011463A1 (en) Diagnosis of unstable angina
KR20160114088A (ko) 진단을 위한 세포 표면 전립선암 항원
AU2015376851A1 (en) Glypican epitopes and uses thereof
KR20180096633A (ko) Il23-길항제에 대한 임상적 반응의 예측인자로서의 ccl20
MX2014001579A (es) Metodos y productos para el diagnostico in vitro, pronosticos in vitro y desarrollo de farmacos contra carcinomas invasivos.
CN110320368A (zh) 基于trem2的诊断试剂盒及其在帕金森病诊断产品上的应用
JP2022506108A5 (https=)
CN108351359A (zh) 用于预测肝硬化患者的肝细胞癌发生风险和预后的方法
KR20190121767A (ko) 항-인간 gpvi 항체를 이용한 혈소판 응집의 억제
JP2021528411A5 (https=)
JPWO2020083979A5 (https=)
CN113366021A (zh) 糖基化Apo J特异性抗体及其用途
RU2021114443A (ru) Антитела, специфические к гликозилированному apoj, и их применение
JP7752112B2 (ja) Iv型コラーゲンのプロテアーゼ媒介分解を測定するネオエピトープ特異的アッセイ
CN111630066A (zh) 靶向白介素-19的化合物和方法
JP2023540617A (ja) がんを評価するためのアッセイ
KR20170138465A (ko) Igf-1r 항체 및 암의 진단을 위한 그의 용도
CA2771954A1 (en) Pneumonia biomarkers
Joachimbauer et al. T-cell activation and fibroblastic BMP4-Gremlin dysregulation indicate disease severity in acute myocarditis
WO2025172467A1 (en) Endotrophin assay